Ref ID: 18722
Author:
T. Lehrnbecher, MD – Professor1, L. Tramsen, MD – Physician 1, S. Perkhofer, PhD – Professor 2, C. Lass-Flörl, MD, PhD – Professor 3, F. Roeger, none – Research Assistant 1, R. Schubert, PhD – Professor 1, S. Schmidt, PhD – Fellow 1;
Author address:
1Johann Wolfgang Goethe-Univ., Frankfurt, Germany, 23fhg-Univ. of Applied Sci. Tyrol, Innsbruck, Austria, 32Dept. of Hygiene, Microbiol., and Social Med., Univ. of Innsbruck, Innsbruck, Austria.
Full conference title:
52nd Annual ICAAC
Date: 9 September 2014
Abstract:
Background: Infections due to Mucormycetes are increasingly reported and have a poor outcome, in particular in allogeneic hematopoietic stem cell transplantation (HSCT). Whereas adoptive immunotherapy transferring donor-derived anti-Aspergillus TH1 cells has been shown to be beneficial in HSCT recipients suffering from invasive aspergillosis, little is known about the cellular immunity against Mucormycetes. Methods: A total of 1×108 peripheral blood mononuclear cells from healthy volunteers were incubated overnight with antigens of Rhizopus oryzae. Stimulated cells were enriched by means of CD154 and interferon (IFN)-γ selection. After further expansion, cells were phenotypically and functionally characterized by flow-cytometry. Results: In all six individual tested, isolated and cultivated cells were characterized as a highly homogenous population of CD4+ T-cells which expressed HLA-DR and CD45RO, but lost CD62L, indicating an activated effector/memory T-helper cell population. Upon restimulation, the cells produced IFN-γ and TNF-α , but no IL-4 or IL-10, indicating a TH1 population. The generated cells were able to proliferate upon restimulation and showed cross-reactivity to other Mucormycetes (e.g., Rhizopus microsporus, Rhizomucor pusillus, and Mucor circinelloides). In addition, the generated cells exhibited a lower alloreactive potential compared to the original cell fraction, and increased the phagocyte activity of granulocytes and monocytes. Conclusions: Our data suggest that donor-derived anti-R. oryzae TH1 cells might be a potential tool for adoptive immunotherapy in allogeneic HSCT recipients suffering from mucormycosis.
Abstract Number: M-1708
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a